Skip to Content
Merck
All Photos(1)

Documents

MHS1

Sigma-Aldrich

Mayer′s Hematoxylin Solution

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

MDL number:
MFCD00078111
UNSPSC Code:
12352200
PubChem Substance ID:
24897405
NACRES:
NA.47

form

solution

Quality Level

500

shelf life

Expiry date on the label.

IVD

for in vitro diagnostic use

concentration

1 g/L

pH

2.4 (25 °C)

application(s)

hematology
histology

storage temp.

room temp

SMILES string

Oc1cc2C[C@@]3(O)COc4c(O)c(O)ccc4[C@H]3c2cc1O

InChI

1S/C16H14O6/c17-10-2-1-8-13-9-4-12(19)11(18)3-7(9)5-16(13,21)6-22-15(8)14(10)20/h1-4,13,17-21H,5-6H2/t13-,16+/m0/s1

InChI key

WZUVPPKBWHMQCE-XJKSGUPXSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

Used as a counterstain for procedures such as immunohistochemistry or laser microdissection.

Application

General purpose nuclear stain, progressive type. Used with hematoxylin and eosin staining.

Other Notes

1 g/L certified hematoxylin

Storage Class Code

12 - Non Combustible Liquids

WGK

WGK 2

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Michael Taylor Hensley et al.
Journal of cellular and molecular medicine, 21(8), 1503-1512 (2017-03-16)
Cardiosphere-derived cells (CDCs) have been shown to reduce scar size and increase viable myocardium in human patients with mild/moderate myocardial infarction. Studies in rodent models suggest that CDC therapy may confer therapeutic benefits in patients with non-ischaemic dilated cardiomyopathy (DCM).
Shih-Jie Jhuo et al.
International journal of molecular sciences, 22(11) (2021-07-03)
Empagliflozin (EMPA) is a sodium-glucose transporter 2 (SGLT2) inhibitor that functions as a new-generation glucose-lowering agent and has been proven to be beneficial for patients with cardiovascular diseases. However, the possible benefits and mechanisms of its antiarrhythmic effects in cardiac
Gretchen M Alicea et al.
Cancer discovery, 10(9), 1282-1295 (2020-06-06)
Older patients with melanoma (>50 years old) have poorer prognoses and response rates to targeted therapy compared with young patients (<50 years old), which can be driven, in part, by the aged microenvironment. Here, we show that aged dermal fibroblasts
Darby A Houck et al.
Orthopaedic journal of sports medicine, 7(12), 2325967119888173-2325967119888173 (2020-01-07)
Arthroscopic capsular release (ACR) for the treatment of adhesive capsulitis of the shoulder can be performed in either the beach-chair (BC) or lateral decubitus (LD) position. To determine the clinical outcomes and recurrence rates after ACR in the BC versus
Amanpreet Kaur et al.
Cancer discovery, 9(1), 64-81 (2018-10-04)
Physical changes in skin are among the most visible signs of aging. We found that young dermal fibroblasts secrete high levels of extracellular matrix (ECM) constituents, including proteoglycans, glycoproteins, and cartilage-linking proteins. The most abundantly secreted was HAPLN1, a hyaluronic
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service